Kathrin Heermeier : NIDDK

Scientific Programs

Kathrin Heermeier

Dr. Kathrin Heermeier joined our laboratory in 1993 to explore the role of the Bcl-2 family of proteins during mammary development, and involution in particular. She had received her Ph.D. from the University of Munich. Kathrin left our laboratory in 1996 and works now as a senior scientist for Aventis in Frankfurt/Germany.

Publications while at LGP

PubMed search

1. Heermeier, K. Benedikt, M., Li. M., Furth, P.A., Nunez, G. and Hennighausen, L. (1996) Induction of the apoptosis proteins bax and bcl-xS coincides with the onset of programmed cell death in involuting mammary epithelial cells. Mech. Of Development 56, 197-207.

2. Li, M., Hu, J., Heermeier, K., Hennighausen, L. and Furth, P.A. (1996) Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53 independent pathways. Cell Growth and Differentiation 7, 13-20.

3. Li, M., Hu, J., Heermeier, K., Hennighausen, L. and Furth, P.A. (1996) Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53 independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth and Differentiation, 7, 3-11.

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation